8-K: Semler Scientific Stockholders Approve Strive Merger

Semler Scientific, Inc. stockholders approved the merger agreement with Strive, Inc. and related executive compensation at a special meeting on January 13, 2026.

Summary

• A special meeting of stockholders was held on January 13, 2026, to vote on proposals related to the merger with Strive, Inc.
• As of the record date, November 19, 2025, there were 15,285,092 shares of common stock outstanding and entitled to vote.
• A quorum was present at the meeting, with 9,409,336 shares, representing 61.6% of the total shares, represented in person or by proxy.
• Proposal 1, the Merger Proposal to approve the Agreement and Plan of Merger with Strive, Inc., was approved with 8,732,675 votes for, 633,524 votes against, and 43,137 abstentions.
• Proposal 2, an advisory vote on executive compensation related to the merger, was approved with 5,733,052 votes for, 3,469,890 votes against, and 206,391 abstentions.
• Proposal 3, the Adjournment Proposal, was not voted on as sufficient votes were already secured to approve the Merger Proposal.

Sentiment

Score: 7

Explanation: The approval of the merger and related compensation indicates a positive step forward for the company's strategic direction. However, the extensive list of forward-looking risks, particularly concerning Bitcoin volatility and integration challenges, tempers the overall sentiment.

Positives

• Stockholders approved the Agreement and Plan of Merger with Strive, Inc., paving the way for the transaction to proceed.
• The advisory proposal on compensation for named executive officers related to the merger also received stockholder approval.
• Sufficient votes were obtained for the Merger Proposal, eliminating the need for an adjournment of the special meeting.

Risks

• Volatility in Bitcoin and risks related to Semler Scientific's Bitcoin treasury strategy and its healthcare business.
• The possibility of an event, change, or circumstance that could lead to the termination of the merger agreement by either Semler Scientific or Strive, Inc.
• The proposed transaction may not close when expected or at all if closing conditions are not met on a timely basis.
• Potential legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected or at all.
• Challenges related to the implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and changes in laws and regulations could impact the combined company.
• The integration of the two companies may prove more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Diversion of management's attention from ongoing business operations and opportunities during the merger process.
• Dilution for existing shareholders caused by Strive's issuance of additional shares of its Class A common stock in connection with the transaction.
• Potential adverse reactions from customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before the closing of the merger.

Future Outlook

The proposed transaction is expected to close, with management anticipating strategic and financial benefits for the combined company. However, the outlook is subject to inherent risks and uncertainties, including Bitcoin volatility, integration challenges, and the realization of anticipated benefits, which could cause actual results to differ materially from these forward-looking expectations.

Management Comments

• Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations.

Industry Context

The approval of the merger between Semler Scientific and Strive, Inc. signifies a strategic move towards consolidation or expansion within Semler Scientific's operational areas, potentially impacting its healthcare business and its Bitcoin treasury strategy. The explicit mention of Bitcoin volatility as a risk factor highlights the increasing trend of companies integrating digital assets into their corporate strategies, a move that introduces both potential opportunities and significant market-related risks.

Comparison to Industry Standards

• The approval of the merger proposal by a substantial majority of votes (8,732,675 for vs. 633,524 against) is consistent with typical outcomes for merger votes where the board and management recommend approval, indicating strong shareholder support for the strategic direction.
• The advisory vote on executive compensation, while approved, saw a notable percentage of votes against (3,469,890 against vs. 5,733,052 for). This level of dissent, while not uncommon for merger-related compensation packages, suggests some shareholder scrutiny regarding the alignment of executive pay with the transaction's value, a common point of contention for institutional investors and proxy advisory firms.

Corporate Governance

Legal Proceedings

• The filing notes a risk regarding "the outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company," indicating a potential for future litigation or regulatory matters related to the merger or ongoing operations.

Stakeholder Impact

• **Shareholders**: The approval of the merger will lead to a combined entity, potentially impacting future share value, dividends, and governance. Strive's share issuance in connection with the transaction will cause dilution.
• **Employees**: The integration of the two companies may lead to changes in employee relationships, roles, and organizational structure, as well as potential adverse reactions.
• **Customers**: There is a risk of potential adverse reactions or changes to business relationships with customers as a result of the merger announcement or completion.
• **Management**: Management's attention will be significantly diverted to the integration process, and executive compensation is tied to the merger's success.

Next Steps

• Completion of the proposed merger transaction between Semler Scientific and Strive, Inc.
• Integration of the combined businesses following the merger.
• Ongoing monitoring and management of risks related to Bitcoin treasury strategies and the healthcare business.

Key Dates

Recommendation

The approval of the merger is a significant strategic event, providing clarity on the company's future direction. However, this filing is primarily a procedural update on a vote. While the merger's completion is now more certain, the extensive list of forward-looking risks, particularly those related to Bitcoin volatility, integration challenges, and potential dilution, suggests a 'hold' position. Investors should await further details on the combined entity's strategy, financial projections, and integration progress before making a more definitive investment decision. The advisory vote on compensation, while approved, also indicates some shareholder scrutiny.

Keywords

Merger, Acquisition, Stockholder Vote, SEC Filing, 8-K, Semler Scientific, Strive Inc, Corporate Governance, Bitcoin Strategy, Healthcare Business, Executive Compensation